6,678 trials
Attention Deficit Hyperactivity Disorder
Primary: Adult ADHD Investigator Symptom Rating Scale (AISRS) — 37.0; 15.0 units on a scale
Relapsing Forms of Multiple Sclerosis
Primary: Change From Baseline in the Global Satisfaction Subscale of the Treatment Satisfaction Questionnaire for Medication (TSQM) at Month 6 — 22.5; 3.5 units on a scale
Schizophrenia
Primary: Number Who Discontinued Medication Within First 6 Study Months — 11; 23 participants
Type 2 Diabetes · Inpatient
Primary: Difference Between Heart Rate Variability Between Intravenous and Subcutaneous Group — 1.0; 2.6 none (ratio) — p=0.05
Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Mean Diurnal Intraocular Pressure (IOP) — 22.3; 22.2; -4.7; -4.0 mm Hg
Postoperative Nausea and Vomiting (PONV) · Nausea
Primary: Proportion of Patients With a Complete Response/Complete Control During the First 24 Hours After Neurological Surgery Under General Anesthesia — 38; 41; 30; 30…
Ulcerative Colitis
Primary: Percentage of Subjects in Complete Remission at Month 12 of Maintenance Phase — 47.8; 26.0 percentage of subjects — p=<0.001
Type 2 Diabetes Mellitus
Primary: Proportion of Patients Reaching HbA1c <7% After 52 Weeks of Treatment Without Confirmed or Severe Hypoglycaemia. — 37.9; 38.2; 39.2; 33.3 percentage of participants
Controlled Ovarian Stimulation · Infertility
Primary: The Oestradiol Concentration on the Day of Ovulation Induction — 11482; 12262 pmol/L
Neonatal Abstinence Syndrome
Primary: Length of Treatment With Opioid Medication — 19.1; 17.7 days
OHSS (Ovarian Hyperstimulation)
Primary: Frequency of Moderate to Severe OHSS. — 0; 2; 2; 0 participants
Arteriosclerosis of Coronary Artery Bypass Graft
Primary: Technical Success (Graft Patency) in a MICS Approach — 100 percentage of grafts
Common Cold
Primary: Adjusted Mean Change From Baseline in Number of Valid Responses to Rapid Visual Information Processing (RVIP) Cognitive Test — 4.8; 1.3 Valid responses — p=0.0008
Depressive Disorder
Primary: Montgomery-Asberg Depression Rating Score (MADRS) — -7.25; -7.13 units on a scale
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in Glycosylated Haemoglobin (HbA1c) From Baseline to Week 11 — -1.04; -0.90 percentage of glycosylated haemoglobin — p=<0.001